September 21, 2022
Naventus Corporate Finance acts as financial advisor to Sprint Bioscience on its equity financing of approximately SEK 30 million.

Naventus Corporate Finance acts as financial advisor to Sprint Bioscience on its equity financing of approximately SEK 30 million.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.